Disease | pancreatic cancer |
Phenotype | C0013292|duodenal obstruction |
Sentences | 7 |
PubMedID- 23597937 | Palliation of biliary and duodenal obstruction in patients with unresectable pancreatic cancer: endoscopy or surgery. |
PubMedID- 21282956 | Covered stent placement for duodenal obstruction in pancreatic cancer. |
PubMedID- 26502467 | [endoscopic ultrasound-guided choledocho-duodenostomy in advanced pancreatic cancer with duodenal obstruction]. |
PubMedID- 20533606 | In two consecutive patients with biliary and duodenal obstruction due to pancreatic cancer, a new biliary metal stent mounted in a slim delivery catheter was placed via a thin forward viewing endoscope after passage across the duodenal stenosis without balloon dilation. |
PubMedID- 22549377 | Similarly, a retrospective comparison of a cohort of 27 patients with pancreatic cancer causing duodenal obstruction treated with endoscopic stenting versus surgical bypass found no difference in survival but median hospital stay of 4 days in the stent group versus 14 days in the surgical group [4]. |
PubMedID- 23617659 | Endoscopic double stenting for the treatment of malignant biliary and duodenal obstruction due to pancreatic cancer. |
PubMedID- 24212633 | Whereas, at the time of diagnosis only about 19% of pancreatic cancer patients present with symptoms of gastroduodenal obstruction, such as nausea and vomiting, 30–50% of all patients will eventually develop malignant gastric outlet obstruction (goo) during the course of their disease, with the necessity for endoscopic or surgical intervention [20]. |
Page: 1